Details about Werner B.F. Brouwer

Access statistics for papers by Werner B.F. Brouwer.

Last updated 2025-03-03. Update your information in the RePEc Author Service.

Short-id: pbr212

Working Papers

2020

1. The Value of Health - Empirical Issues when Estimating the Monetary Value of a QALY Based on Well-Being
   SOEPpapers on Multidisciplinary Panel Data Research, DIW Berlin, The German Socio-Economic Panel (SOEP) View citations (1)

2016

2. An elicitation of utility for quality of life under prospect theory
   Post-Print, HAL View citations (30)
   See also Journal Article An elicitation of utility for quality of life under prospect theory, Journal of Health Economics, Elsevier (2016) View citations (30) (2016)
3. From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries
   Post-Print, HAL View citations (8)
   See also Journal Article From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries, Social Science & Medicine, Elsevier (2016) View citations (10) (2016)

2015

4. Estimating sign-dependent societal preferences for quality of life
   Post-Print, HAL View citations (11)
   Also in MPRA Paper, University Library of Munich, Germany (2014)
   See also Journal Article Estimating sign-dependent societal preferences for quality of life, Journal of Health Economics, Elsevier (2015) View citations (11) (2015)
5. Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology
   Post-Print, HAL View citations (23)
   See also Journal Article Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology, Social Science & Medicine, Elsevier (2015) View citations (26) (2015)

2014

6. New findings from the TTO for income approach to elicit willingness to pay for a QALY
   MPRA Paper, University Library of Munich, Germany

2013

7. A quantification of prospect theory in the health domain
   Economics Working Paper Archive (University of Rennes & University of Caen), Center for Research in Economics and Management (CREM), University of Rennes, University of Caen and CNRS View citations (47)
8. Prospect theory in the health domain: A quantitative assessment
   Post-Print, HAL View citations (45)
   Also in MPRA Paper, University Library of Munich, Germany (2013) View citations (50)
   See also Journal Article Prospect theory in the health domain: A quantitative assessment, Journal of Health Economics, Elsevier (2013) View citations (45) (2013)

2012

9. Deriving time discounting correction factors for TTO tariffs
   MPRA Paper, University Library of Munich, Germany View citations (1)
   See also Journal Article DERIVING TIME DISCOUNTING CORRECTION FACTORS FOR TTO TARIFFS, Health Economics, John Wiley & Sons, Ltd. (2014) View citations (3) (2014)
10. In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks
    MPRA Paper, University Library of Munich, Germany View citations (3)
    See also Journal Article In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks, Journal of Economic Psychology, Elsevier (2013) View citations (18) (2013)
11. Your right arm for a publication in AER?
    MPRA Paper, University Library of Munich, Germany View citations (2)
    See also Journal Article YOUR RIGHT ARM FOR A PUBLICATION IN AER?, Economic Inquiry, Western Economic Association International (2014) View citations (27) (2014)

2011

12. Economic evaluation and the postponement of health care costs
    Other publications TiSEM, Tilburg University, School of Economics and Management View citations (8)
    See also Journal Article Economic evaluation and the postponement of health care costs, Health Economics, John Wiley & Sons, Ltd. (2011) View citations (7) (2011)

2009

13. Measuring the value of life: exploring a new method for deriving the monetary value of a QALY
    MPRA Paper, University Library of Munich, Germany View citations (1)
14. The impact of losses in income due to ill health: does the EQ-5D reflect lost earnings?
    MPRA Paper, University Library of Munich, Germany View citations (2)

Journal Articles

2025

1. Preferences of citizens in Peru for school opening during a public-health crisis: A participatory value evaluation study
   Social Science & Medicine, 2025, 365, (C)

2024

2. Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic
   The European Journal of Health Economics, 2024, 25, (4), 563-578
3. Correction: Braving the waves: exploring capability well-being patterns in seven European countries during the COVID-19 pandemic
   The European Journal of Health Economics, 2024, 25, (1), 187-187
4. Development and Content Validation of the 10-item Well-being Instrument (WiX) for use in Economic Evaluation Studies
   Applied Research in Quality of Life, 2024, 19, (2), 381-413
5. Estimating a Preference-Based Value Set for the Mental Health Quality of Life Questionnaire (MHQoL)
   Medical Decision Making, 2024, 44, (1), 64-75
6. Examining the Effect of Depicting a Patient Affected by a Negative Reimbursement Decision in Healthcare on Public Disagreement with the Decision
   PharmacoEconomics, 2024, 42, (8), 879-894
7. Obtaining preference scores for an abbreviated self-completion version of the Teen-Addiction Severity Index (ASC T-ASI) to value therapy outcomes of systemic family interventions: a discrete choice experiment
   The European Journal of Health Economics, 2024, 25, (5), 903-913
8. On spillovers in economic evaluations: definition, mapping review and research agenda
   The European Journal of Health Economics, 2024, 25, (7), 1239-1260
9. Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task Force
   PharmacoEconomics, 2024, 42, (3), 343-362
10. The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands
    The European Journal of Health Economics, 2024, 25, (8), 1449-1459

2023

11. Adaptation in life satisfaction and self-assessed health to disability - Evidence from the UK
    Social Science & Medicine, 2023, 328, (C) View citations (1)
12. Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries
    PharmacoEconomics, 2023, 41, (10), 1389-1402
13. Moving Forward with Taking a Societal Perspective: A Themed Issue on Productivity Costs, Consumption Costs and Informal Care Costs
    PharmacoEconomics, 2023, 41, (9), 1027-1030
14. Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review
    PharmacoEconomics, 2023, 41, (9), 1031-1050 View citations (1)
15. Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects
    PharmacoEconomics, 2023, 41, (9), 1103-1115 View citations (2)
16. Public preferences for policies promoting a healthy diet: a discrete choice experiment
    The European Journal of Health Economics, 2023, 24, (9), 1429-1440 View citations (2)
17. The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
    PharmacoEconomics, 2023, 41, (6), 607-617 View citations (3)
18. What Constitutes Well-being? Five Views Among Adult People from the Netherlands on what is Important for a Good Life
    Applied Research in Quality of Life, 2023, 18, (6), 3141-3167 View citations (1)
19. Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaks
    The European Journal of Health Economics, 2023, 24, (6), 967-986

2022

20. Coverage with evidence development for medical devices in Europe: Can practice meet theory?
    Health Economics, 2022, 31, (S1), 179-194 View citations (2)
21. Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe?
    The European Journal of Health Economics, 2022, 23, (1), 81-94
22. Estimating an anchored utility tariff for the well-being of older people measure (WOOP) for the Netherlands
    Social Science & Medicine, 2022, 301, (C) View citations (3)
23. Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries
    Health Economics, 2022, 31, (S1), 195-206
24. In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era
    PharmacoEconomics, 2022, 40, (1), 7-11
25. Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic
    PharmacoEconomics, 2022, 40, (1), 77-90 View citations (5)
26. Reference‐dependent age weighting of quality‐adjusted life years
    Health Economics, 2022, 31, (12), 2515-2536
27. The relative value of carer and patient quality of life: A person trade-off (PTO) study
    Social Science & Medicine, 2022, 292, (C) View citations (1)

2021

28. Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride?
    Health Economics, Policy and Law, 2021, 16, (4), 440-456 View citations (2)
29. Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
    The European Journal of Health Economics, 2021, 22, (8), 1253-1273 View citations (4)
30. Distributional consequences of including survivor costs in economic evaluations
    Health Economics, 2021, 30, (10), 2606-2613
31. Estimating an exchange‐rate between care‐related and health‐related quality of life outcomes for economic evaluation: An application of the wellbeing valuation method
    Health Economics, 2021, 30, (11), 2847-2857 View citations (1)
32. Estimating the costs of non-medical consumption in life-years gained for economic evaluations
    Social Science & Medicine, 2021, 289, (C) View citations (2)
33. Life satisfaction: The role of domain‐specific reference points
    Health Economics, 2021, 30, (11), 2766-2779 View citations (1)
34. The value of health—Empirical issues when estimating the monetary value of a quality‐adjusted life year based on well‐being data
    Health Economics, 2021, 30, (8), 1849-1870 View citations (1)
35. Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others
    The European Journal of Health Economics, 2021, 22, (5), 679-697 View citations (3)
36. What works better for preference elicitation among older people? Cognitive burden of discrete choice experiment and case 2 best-worst scaling in an online setting
    Journal of choice modelling, 2021, 38, (C) View citations (4)
37. Willingness to pay for quality and length of life gains in end of life patients of different ages
    Social Science & Medicine, 2021, 279, (C)

2020

38. Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature
    The European Journal of Health Economics, 2020, 21, (9), 1329-1350
39. Development of Population Tariffs for the CarerQol Instrument for Hungary, Poland and Slovenia: A Discrete Choice Experiment Study to Measure the Burden of Informal Caregiving
    PharmacoEconomics, 2020, 38, (6), 633-643
40. Estimating the monetary value of health and capability well-being applying the well-being valuation approach
    The European Journal of Health Economics, 2020, 21, (8), 1235-1244 View citations (4)
41. Happy with Your Capabilities? Valuing ICECAP-O and ICECAP-A States Based on Experienced Utility Using Subjective Well-Being Data
    Medical Decision Making, 2020, 40, (4), 498-510 View citations (3)
42. How does participating in a deliberative citizens panel on healthcare priority setting influence the views of participants?
    Health Policy, 2020, 124, (2), 143-151 View citations (4)
43. Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble
    Journal of Health Economics, 2020, 71, (C) View citations (6)
44. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
    The European Journal of Health Economics, 2020, 21, (7), 977-982 View citations (42)
45. Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations
    PLOS ONE, 2020, 15, (9), 1-12 View citations (1)
46. United but divided: Policy responses and people’s perceptions in the EU during the COVID-19 outbreak
    Health Policy, 2020, 124, (9), 909-918 View citations (24)
47. Well-being of Older People (WOOP): Quantitative validation of a new outcome measure for use in economic evaluations
    Social Science & Medicine, 2020, 259, (C) View citations (4)
48. What is it going to be, TTO or SG? A direct test of the validity of health state valuation
    Health Economics, 2020, 29, (11), 1475-1481 View citations (3)
49. Willingness to pay for an early warning system for infectious diseases
    The European Journal of Health Economics, 2020, 21, (5), 763-773 View citations (8)

2019

50. A QALY loss is a QALY loss is a QALY loss: a note on independence of loss aversion from health states
    The European Journal of Health Economics, 2019, 20, (3), 419-426 View citations (2)
51. A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending
    Health Economics, 2019, 28, (1), 87-100 View citations (3)
52. Future Costs in Cost-Effectiveness Analyses: Past, Present, Future
    PharmacoEconomics, 2019, 37, (2), 119-130 View citations (5)
53. Future unrelated medical costs need to be considered in cost effectiveness analysis
    The European Journal of Health Economics, 2019, 20, (1), 1-5 View citations (3)
54. How to value safety in economic evaluations in health care? A review of applications in different sectors
    The European Journal of Health Economics, 2019, 20, (7), 1041-1061 View citations (4)
55. Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D
    PharmacoEconomics, 2019, 37, (4), 609-620 View citations (2)
56. QALYs without bias? Nonparametric correction of time trade‐off and standard gamble weights based on prospect theory
    Health Economics, 2019, 28, (7), 843-854 View citations (5)
57. Severity-Adjusted Probability of Being Cost Effective
    PharmacoEconomics, 2019, 37, (9), 1155-1163 View citations (2)
58. The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra
    PharmacoEconomics, 2019, 37, (4), 451-456 View citations (8)
59. The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice Experiment
    PharmacoEconomics, 2019, 37, (4), 531-540 View citations (5)
60. The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys
    The European Journal of Health Economics, 2019, 20, (1), 5-16 View citations (5)
61. Views of older people in the Netherlands on wellbeing: A Q-methodology study
    Social Science & Medicine, 2019, 240, (C) View citations (5)
62. When is it too expensive? Cost-effectiveness thresholds and health care decision-making
    The European Journal of Health Economics, 2019, 20, (2), 175-180 View citations (12)

2018

63. Discounting in Economic Evaluations
    PharmacoEconomics, 2018, 36, (7), 745-758 View citations (16)
64. Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands
    Health Policy, 2018, 122, (6), 621-629 View citations (14)
65. New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year
    The European Journal of Health Economics, 2018, 19, (2), 277-291 View citations (3)
66. What should we know about the person behind a TTO?
    The European Journal of Health Economics, 2018, 19, (9), 1207-1211 View citations (4)

2017

67. A short note on measuring subjective life expectancy: survival probabilities versus point estimates
    The European Journal of Health Economics, 2017, 18, (1), 7-12 View citations (2)
68. Acceptable health and priority weighting: Discussing a reference-level approach using sufficientarian reasoning
    Social Science & Medicine, 2017, 181, (C), 158-167 View citations (6)
69. Health losses at the end of life: a Bayesian mixed beta regression approach
    Journal of the Royal Statistical Society Series A, 2017, 180, (3), 723-749 View citations (1)
70. Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US
    PharmacoEconomics, 2017, 35, (4), 469-478 View citations (5)

2016

71. A Framework for Including Family Health Spillovers in Economic Evaluation
    Medical Decision Making, 2016, 36, (2), 176-186 View citations (12)
72. Altruistic Preferences in Time Tradeoff
    Medical Decision Making, 2016, 36, (2), 187-198 View citations (3)
73. An elicitation of utility for quality of life under prospect theory
    Journal of Health Economics, 2016, 48, (C), 121-134 View citations (30)
    See also Working Paper An elicitation of utility for quality of life under prospect theory, Post-Print (2016) View citations (30) (2016)
74. Are some QALYs more equal than others?
    The European Journal of Health Economics, 2016, 17, (2), 117-127 View citations (5)
75. Competition among health care providers: helpful or harmful?
    The European Journal of Health Economics, 2016, 17, (3), 229-233 View citations (20)
76. From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare
    PharmacoEconomics, 2016, 34, (11), 1071-1074 View citations (12)
77. From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries
    Social Science & Medicine, 2016, 166, (C), 205-213 View citations (10)
    See also Working Paper From representing views to representativeness of views: Illustrating a new (Q2S) approach in the context of health care priority setting in nine European countries, Post-Print (2016) View citations (8) (2016)
78. Future Costs, Fixed Healthcare Budgets, and the Decision Rules of Cost‐Effectiveness Analysis
    Health Economics, 2016, 25, (2), 237-248 View citations (13)
79. Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis
    Health Economics, 2016, 25, (12), 1529-1544 View citations (18)
80. Patient and general public preferences for health states: A call to reconsider current guidelines
    Social Science & Medicine, 2016, 165, (C), 66-74 View citations (30)
81. The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries
    Health Economics, 2016, 25, (8), 1005-1019 View citations (4)
82. Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal
    Health Economics, 2016, 25, (8), 933-938 View citations (4)

2015

83. Comparing WTP Values of Different Types of QALY Gain Elicited from the General Public
    Health Economics, 2015, 24, (3), 280-293 View citations (21)
84. Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life
    The European Journal of Health Economics, 2015, 16, (8), 801-811
85. Do people desire to be healthier than other people? A short note on positional concerns for health
    The European Journal of Health Economics, 2015, 16, (1), 47-54 View citations (5)
86. Estimating sign-dependent societal preferences for quality of life
    Journal of Health Economics, 2015, 43, (C), 229-243 View citations (11)
    See also Working Paper Estimating sign-dependent societal preferences for quality of life, Post-Print (2015) View citations (11) (2015)
87. Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology
    Social Science & Medicine, 2015, 126, (C), 128-137 View citations (26)
    See also Working Paper Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology, Post-Print (2015) View citations (23) (2015)
88. Quality of Life and Time to Death
    Medical Decision Making, 2015, 35, (3), 316-327 View citations (2)
89. Unpaid work in health economic evaluations
    Social Science & Medicine, 2015, 144, (C), 127-137 View citations (7)
90. Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment
    PharmacoEconomics, 2015, 33, (12), 1289-1300 View citations (11)

2014

91. A Discrete Choice Experiment to Obtain a Tariff for Valuing Informal Care Situations Measured with the CarerQol Instrument
    Medical Decision Making, 2014, 34, (1), 84-96 View citations (4)
92. DERIVING TIME DISCOUNTING CORRECTION FACTORS FOR TTO TARIFFS
    Health Economics, 2014, 23, (4), 410-425 View citations (3)
    See also Working Paper Deriving time discounting correction factors for TTO tariffs, MPRA Paper (2012) View citations (1) (2012)
93. How to Estimate Productivity Costs in Economic Evaluations
    PharmacoEconomics, 2014, 32, (4), 335-344 View citations (20)
94. Predicting productivity based on EQ-5D: an explorative study
    The European Journal of Health Economics, 2014, 15, (5), 465-475 View citations (3)
95. Quality of life instruments for economic evaluations in health and social care for older people: A systematic review
    Social Science & Medicine, 2014, 102, (C), 83-93 View citations (25)
96. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
    The European Journal of Health Economics, 2014, 15, (1), 83-92 View citations (2)
    Also in The European Journal of Health Economics, 2014, 15, (1), 83-92 (2014)
97. The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk
    PharmacoEconomics, 2014, 32, (1), 75-86 View citations (18)
98. YOUR RIGHT ARM FOR A PUBLICATION IN AER?
    Economic Inquiry, 2014, 52, (1), 495-502 View citations (27)
    See also Working Paper Your right arm for a publication in AER?, MPRA Paper (2012) View citations (2) (2012)

2013

99. A new prevention paradox: The trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers
    Social Science & Medicine, 2013, 76, (C), 150-158 View citations (1)
100. Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall
     The European Journal of Health Economics, 2013, 14, (1), 107-115 View citations (21)
101. How to Include Informal Care in Economic Evaluations
     PharmacoEconomics, 2013, 31, (12), 1105-1119 View citations (28)
102. In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks
     Journal of Economic Psychology, 2013, 39, (C), 126-140 View citations (18)
     See also Working Paper In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks, MPRA Paper (2012) View citations (3) (2012)
103. LEAD TIME TTO: LEADING TO BETTER HEALTH STATE VALUATIONS?
     Health Economics, 2013, 22, (4), 376-392 View citations (15)
104. Measuring the affordability of medicines: Importance and challenges
     Health Policy, 2013, 112, (1), 45-52 View citations (3)
105. Pharmacoeconomic Guidelines Should Prescribe Inclusion of Indirect Medical Costs! A Response to Grima et al
     PharmacoEconomics, 2013, 31, (5), 369-373 View citations (2)
106. Prospect theory in the health domain: A quantitative assessment
     Journal of Health Economics, 2013, 32, (6), 1057-1065 View citations (45)
     See also Working Paper Prospect theory in the health domain: A quantitative assessment, Post-Print (2013) View citations (45) (2013)
107. VALUING QALY GAINS BY APPLYING A SOCIETAL PERSPECTIVE
     Health Economics, 2013, 22, (10), 1272-1281 View citations (12)

2012

108. A test of independence of discounting from quality of life
     Journal of Health Economics, 2012, 31, (1), 22-34 View citations (4)
109. Does the EQ-5D Reflect Lost Earnings?
     PharmacoEconomics, 2012, 30, (1), 47-61 View citations (5)
110. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation
     Journal of Health Economics, 2012, 31, (1), 158-168 View citations (18)
111. Preference-Based Health-Related Quality-of-Life Outcomes in Children with Autism Spectrum Disorders
     PharmacoEconomics, 2012, 30, (8), 661-679 View citations (1)
112. Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects
     Social Science & Medicine, 2012, 75, (11), 1981-1988 View citations (12)
113. Putting your money where your mouth is: Parents' valuation of good oral health of their children
     Social Science & Medicine, 2012, 75, (12), 2200-2206 View citations (1)
114. The evaluation of lifestyle interventions in the Netherlands
     Health Economics, Policy and Law, 2012, 7, (2), 243-261 View citations (1)
115. The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design
     The European Journal of Health Economics, 2012, 13, (4), 491-500 View citations (7)

2011

116. Discounting and decision making in the economic evaluation of health‐care technologies
     Health Economics, 2011, 20, (1), 2-15 View citations (31)
117. Discounting future health gains: an empirical enquiry into the influence of growing life expectancy
     Health Economics, 2011, 20, (1), 111-119
118. Do Productivity Costs Matter?
     PharmacoEconomics, 2011, 29, (7), 601-619 View citations (16)
119. Economic evaluation and the postponement of health care costs
     Health Economics, 2011, 20, (4), 432-445 View citations (7)
     See also Working Paper Economic evaluation and the postponement of health care costs, Other publications TiSEM (2011) View citations (8) (2011)
120. Health Effects in Significant Others
     Medical Decision Making, 2011, 31, (2), 292-298 View citations (9)

2010

121. Caring for and caring about: Disentangling the caregiver effect and the family effect
     Journal of Health Economics, 2010, 29, (4), 549-556 View citations (71)
122. Piecing the jigsaw puzzle of adolescent happiness
     Journal of Economic Psychology, 2010, 31, (6), 923-935 View citations (16)
123. Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World
     PLOS Medicine, 2010, 7, (8), 1-8 View citations (8)
124. The efficiency frontier approach to economic evaluation: will it help German policy making?
     Health Economics, 2010, 19, (10), 1128-1131 View citations (5)
125. The value of informal care–a further investigation of the feasibility of contingent valuation in informal caregivers
     Health Economics, 2010, 19, (7), 755-771 View citations (14)

2009

126. Some pain, no gain: experiences with the no-claim rebate in the Dutch health care system
     Health Economics, Policy and Law, 2009, 4, (4), 405-424 View citations (9)
127. The Incorporation of Income and Leisure in Health State Valuations When the Measure Is Silent: An Empirical Inquiry into the Sound of Silence
     Medical Decision Making, 2009, 29, (4), 503-512 View citations (5)
128. The correction of TTO-scores for utility curvature using a risk-free utility elicitation method
     Journal of Health Economics, 2009, 28, (1), 234-243 View citations (18)
129. The influence of subjective life expectancy on health state valuations using a 10 year TTO
     Health Economics, 2009, 18, (5), 549-558 View citations (21)

2008

130. Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO‐measurement
     Health Economics, 2008, 17, (7), 877-885 View citations (19)
131. Future costs in economic evaluation: A comment on Lee
     Journal of Health Economics, 2008, 27, (6), 1645-1649 View citations (10)
132. Give me a break!: Informal caregiver attitudes towards respite care
     Health Policy, 2008, 88, (1), 73-87 View citations (9)
133. Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health Expenditure
     PLOS Medicine, 2008, 5, (2), 1-8 View citations (17)
134. Welfarism vs. extra-welfarism
     Journal of Health Economics, 2008, 27, (2), 325-338 View citations (54)
135. When Time is Not on Your Side
     The Patient: Patient-Centered Outcomes Research, 2008, 1, (1), 55-71 View citations (1)

2007

136. Care for a break? An investigation of informal caregivers' attitudes toward respite care using Q-methodology
     Health Policy, 2007, 83, (2-3), 332-342 View citations (12)
137. Discounting in economic evaluations: stepping forward towards optimal decision rules
     Health Economics, 2007, 16, (3), 307-317 View citations (33)
138. Increasing tobacco taxes: A cheap tool to increase public health
     Health Policy, 2007, 82, (2), 142-152 View citations (8)
139. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio
     Health Economics, 2007, 16, (4), 421-433 View citations (15)
140. When time is more than money: The allocation of time between work and leisure in HIV-infected patients
     Social Science & Medicine, 2007, 64, (11), 2355-2361 View citations (6)

2006

141. "Everyone dies, so you might as well have fun!" Attitudes of Dutch youths about their health lifestyle
     Social Science & Medicine, 2006, 63, (10), 2628-2639 View citations (7)
142. Economic valuation of informal care: Lessons from the application of the opportunity costs and proxy good methods
     Social Science & Medicine, 2006, 62, (4), 835-845 View citations (46)
143. Respite care--An explorative study of demand and use in Dutch informal caregivers
     Health Policy, 2006, 78, (2-3), 194-208 View citations (3)
144. With a little help from an anchor: Discussion and evidence of anchoring effects in contingent valuation
     Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), 2006, 35, (5), 836-853 View citations (13)

2005

145. Acceptability of less than perfect health states
     Social Science & Medicine, 2005, 60, (2), 237-246 View citations (17)
146. Corrigendum to "Decision makers' views on health care objectives and budget constraints: results from a pilot study" [Health Policy 70 (2004) 33-48]
     Health Policy, 2005, 74, (1), 109-111
147. Economic valuation of informal care: The conjoint measurement method applied to informal caregiving
     Social Science & Medicine, 2005, 61, (6), 1342-1355 View citations (32)
148. Economic valuation of informal care: the contingent valuation method applied to informal caregiving
     Health Economics, 2005, 14, (2), 169-183 View citations (40)
149. Expectations regarding length and health related quality of life: Some empirical findings
     Social Science & Medicine, 2005, 61, (5), 1083-1094 View citations (19)
150. Influence of waiting time on cost-effectiveness
     Social Science & Medicine, 2005, 60, (11), 2501-2504 View citations (7)
151. Is silence golden? A test of the incorporation of the effects of ill‐health on income and leisure in health state valuations
     Health Economics, 2005, 14, (6), 643-647 View citations (11)
152. Practice guidelines based on clinical and economic evidence
     The European Journal of Health Economics, 2005, 6, (2), 91-93
153. Process utility from providing informal care: the benefit of caring
     Health Policy, 2005, 74, (1), 85-99 View citations (55)

2004

154. Decision makers' views on health care objectives and budget constraints: results from a pilot study
     Health Policy, 2004, 70, (1), 33-48 View citations (15)
155. Discounting in decision making: the consistency argument revisited empirically
     Health Policy, 2004, 67, (2), 187-194 View citations (2)
156. Economic valuation of informal care
     The European Journal of Health Economics, 2004, 5, (1), 36-45 View citations (83)
157. The desire for support and respite care: preferences of Dutch informal caregivers
     Health Policy, 2004, 68, (3), 309-320 View citations (7)
158. The influence of subjective expectations about length and quality of life on time trade‐off answers
     Health Economics, 2004, 13, (8), 819-823 View citations (12)

2003

159. Should I stay or should I go? Waiting lists and cross-border care in the Netherlands
     Health Policy, 2003, 63, (3), 289-298 View citations (8)
160. The missing link: on the line between C and E
     Health Economics, 2003, 12, (8), 629-636 View citations (8)

2002

161. Productivity costs before and after absence from work: as important as common?
     Health Policy, 2002, 61, (2), 173-187 View citations (7)
162. Rationalising rationing: economic and other considerations in the debate about funding of Viagra
     Health Policy, 2002, 59, (1), 53-63 View citations (8)

2001

163. Handbook of Health Economics
     Journal of Health Economics, 2001, 20, (5), 855-879 View citations (2)

2000

164. On the economic foundations of CEA. Ladies and gentlemen, take your positions!
     Journal of Health Economics, 2000, 19, (4), 439-459 View citations (37)

1999

165. Priority care for employees: A blessing in disguise?
     Health Economics, 1999, 8, (1), 65-73 View citations (11)
166. Private clinics for employees as a Dutch solution for waiting lists: economic and legal arguments
     Health Policy, 1999, 47, (1), 1-17 View citations (9)
167. Productivity losses without absence: measurement validation and empirical evidence
     Health Policy, 1999, 48, (1), 13-27 View citations (10)

1997

168. Productivity Costs Measurement Through Quality of Life? A Response to the Recommendation of the Washington Panel
     Health Economics, 1997, 6, (3), 253-259 View citations (36)
169. Productivity costs in cost‐effectiveness analysis: numerator or denominator: a further discussion
     Health Economics, 1997, 6, (5), 511-514 View citations (26)